These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 37642974)

  • 1. Pharmacological evaluations of amide carboxylates as potential anti-Alzheimer agents: anti-radicals, enzyme inhibition, simulation and behavioral studies in animal models.
    Mahnashi MH; Ali S; M Alshehri O; Almazni IA; Asiri SA; Sadiq A; Zafar R; Jan MS
    J Biomol Struct Dyn; 2023 Aug; ():1-20. PubMed ID: 37642974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective Application of Two New Pyridine-Based Zinc (II) Amide Carboxylate in Management of Alzheimer's Disease: Synthesis, Characterization, Computational and in vitro Approaches.
    Zafar R; Naureen H; Zubair M; Shahid K; Saeed Jan M; Akhtar S; Ahmad H; Waseem W; Haider A; Ali S; Tariq M; Sadiq A
    Drug Des Devel Ther; 2021; 15():2679-2694. PubMed ID: 34188447
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Zinc metal carboxylates as potential anti-Alzheimer's candidate:
    Zafar R; Zubair M; Ali S; Shahid K; Waseem W; Naureen H; Haider A; Jan MS; Ullah F; Sirajuddin M; Sadiq A
    J Biomol Struct Dyn; 2021 Feb; 39(3):1044-1054. PubMed ID: 32013770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amiridine-piperazine hybrids as cholinesterase inhibitors and potential multitarget agents for Alzheimer's disease treatment.
    Makhaeva GF; Lushchekina SV; Kovaleva NV; Yu Astakhova T; Boltneva NP; Rudakova EV; Serebryakova OG; Proshin AN; Serkov IV; Trofimova TP; Tafeenko VA; Radchenko EV; Palyulin VA; Fisenko VP; Korábečný J; Soukup O; Richardson RJ
    Bioorg Chem; 2021 Jul; 112():104974. PubMed ID: 34029971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ultrasound-Assisted Synthesis of Piperidinyl-Quinoline Acylhydrazones as New Anti-Alzheimer's Agents: Assessment of Cholinesterase Inhibitory Profile, Molecular Docking Analysis, and Drug-like Properties.
    Munir R; Zaib S; Zia-Ur-Rehman M; Hussain N; Chaudhry F; Younas MT; Zahra FT; Tajammul Z; Javid N; Dera AA; Ogaly HA; Khan I
    Molecules; 2023 Feb; 28(5):. PubMed ID: 36903376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring 3-Benzyloxyflavones as new lead cholinesterase inhibitors: synthesis, structure-activity relationship and molecular modelling simulations.
    Mughal EU; Sadiq A; Ayub M; Naeem N; Javid A; Sumrra SH; Zafar MN; Khan BA; Malik FP; Ahmed I
    J Biomol Struct Dyn; 2021 Oct; 39(16):6154-6167. PubMed ID: 32752941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Further SAR studies on natural template based neuroprotective molecules for the treatment of Alzheimer's disease.
    Singh YP; Shankar G; Jahan S; Singh G; Kumar N; Barik A; Upadhyay P; Singh L; Kamble K; Singh GK; Tiwari S; Garg P; Gupta S; Modi G
    Bioorg Med Chem; 2021 Sep; 46():116385. PubMed ID: 34481338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel tacrine-based acetylcholinesterase inhibitors as potential agents for the treatment of Alzheimer's disease: Quinolotacrine hybrids.
    Sadafi Kohnehshahri M; Chehardoli G; Bahiraei M; Akbarzadeh T; Ranjbar A; Rastegari A; Najafi Z
    Mol Divers; 2022 Feb; 26(1):489-503. PubMed ID: 34491490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis, crystal structure,
    Kausar N; Murtaza S; Arshad MN; Zaib Saleem RS; Asiri AM; Kausar S; Altaf AA; Tatheer A; Elnaggar AY; El-Bahy SM
    RSC Adv; 2021 Dec; 12(1):154-167. PubMed ID: 35424495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bis-Amiridines as Acetylcholinesterase and Butyrylcholinesterase Inhibitors:
    Makhaeva GF; Kovaleva NV; Boltneva NP; Rudakova EV; Lushchekina SV; Astakhova TY; Serkov IV; Proshin AN; Radchenko EV; Palyulin VA; Korabecny J; Soukup O; Bachurin SO; Richardson RJ
    Molecules; 2022 Feb; 27(3):. PubMed ID: 35164325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, Characterization and Cholinesterase Inhibition Studies of New Arylidene Aminothiazolylethanone Derivatives.
    Channar PA; Shah MS; Saeed A; Khan SU; Larik FA; Shabir G; Iqbal J
    Med Chem; 2017; 13(7):648-653. PubMed ID: 28266279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-target approach for Alzheimer's disease treatment: computational biomolecular modeling of cholinesterase enzymes with a novel 4-
    Adeowo FY; Ejalonibu MA; Elrashedy AA; Lawal MM; Kumalo HM
    J Biomol Struct Dyn; 2021 Jul; 39(11):3825-3841. PubMed ID: 33030113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New Hybrids of 4-Amino-2,3-polymethylene-quinoline and
    Makhaeva GF; Kovaleva NV; Boltneva NP; Lushchekina SV; Astakhova TY; Rudakova EV; Proshin AN; Serkov IV; Radchenko EV; Palyulin VA; Bachurin SO; Richardson RJ
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, Synthesis, and Biological Evaluation of Novel Indanone Derivatives as Cholinesterase Inhibitors for Potential Use in Alzheimer's Disease.
    Etemadi A; Hemmati S; Shahrivar-Gargari M; Abibiglue YT; Bavili A; Hamzeh-Mivehroud M; Dastmalchi S
    Chem Biodivers; 2023 Aug; 20(8):e202300075. PubMed ID: 37458518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative in-vitro anti-inflammatory, anticholinesterase and antidiabetic evaluation: computational and kinetic assessment of succinimides cyano-acetate derivatives.
    Pervaiz A; Jan MS; Hassan Shah SM; Khan A; Zafar R; Ansari B; Shahid M; Hussain F; Ijaz Khan M; Zeb A; Mukarram Shah SM
    J Biomol Struct Dyn; 2022 May; ():1-14. PubMed ID: 35507043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, molecular modeling and neuroprotective effects of a new framework of cholinesterase inhibitors for Alzheimer's disease.
    Zanon VS; Lima JA; Amaral RF; Lima FRS; Kitagawa DAS; França TCC; Vargas MD
    J Biomol Struct Dyn; 2021 Oct; 39(16):6112-6125. PubMed ID: 32715924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of Novel Benzoxazole-Oxadiazole Derivatives as Effective Anti-Alzheimer's Agents: In Vitro and In Silico Approaches.
    Anwar S; Rehman W; Hussain R; Khan S; Alanazi MM; Alsaif NA; Khan Y; Iqbal S; Naz A; Hashmi MA
    Pharmaceuticals (Basel); 2023 Jun; 16(7):. PubMed ID: 37513821
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory activities of major anthraquinones and other constituents from Cassia obtusifolia against β-secretase and cholinesterases.
    Jung HA; Ali MY; Jung HJ; Jeong HO; Chung HY; Choi JS
    J Ethnopharmacol; 2016 Sep; 191():152-160. PubMed ID: 27321278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of new phenyl sulfonyl-pyrimidine carboxylate derivatives as the potential multi-target drugs with effective anti-Alzheimer's action: Design, synthesis, crystal structure and in-vitro biological evaluation.
    Manzoor S; Prajapati SK; Majumdar S; Raza MK; Gabr MT; Kumar S; Pal K; Rashid H; Kumar S; Krishnamurthy S; Hoda N
    Eur J Med Chem; 2021 Apr; 215():113224. PubMed ID: 33582578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Design, synthesis, and biological evaluation of thienopyrimidine and thienotriazine derivatives as multitarget anti-Alzheimer agents.
    Eissa KI; Kamel MM; Mohamed LW; Galal MA; Kassab AE
    Drug Dev Res; 2022 Sep; 83(6):1394-1407. PubMed ID: 35749685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.